What podcasts say about Cyriac Roeding

Every statement, with the speaker, the exact quote and the moment it was said.

What Cyriac Roeding has said on podcasts

27 statements · 21 positive · 5 negative · 1 neutral

on software-based disease treatmentPositiveOct 5, 2026· Business Of Biotech
Software may eventually treat many diseases.
“Perhaps one day we will be able to treat many diseases by using software.”
Listen at 13:27
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on cancer drugsNegativeOct 5, 2026· Business Of Biotech
Cancer drugs cause major toxicities in the body.
“The main problem we're trying to attack is what we believe is the number one problem of all cancer drugs, which is when they go into the body, they cause major toxicities.”
Listen at 20:43
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on tumor-localized drug productionPositiveOct 5, 2026· Business Of Biotech
Tumor-localized drug production would limit systemic toxicity.
“If you could do that, then you would suddenly have very limited systemic toxicity.”
Listen at 22:27
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s cancer genetic-switch approachPositiveOct 5, 2026· Business Of Biotech
Early’s approach may make cold tumors susceptible to immuno-oncology drugs.
“You could even potentially turn cold tumors hot, meaning make them susceptible for immuno-oncology drugs by inflaming them from the inside.”
Listen at 22:42
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on checkpoint inhibitor drugsNegativeOct 5, 2026· Business Of Biotech
Checkpoint inhibitors activate in about 35% of patients.
“They only activate in about 35% of all patients, meaning two-thirds of all patients show no response at all.”
Listen at 23:19
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s synthetic genetic switchesPositiveOct 5, 2026· Business Of Biotech
Early uses AI to create synthetic DNA genetic switches.
“We use AI to create the first fully synthetic genetic switches made out of DNA code that get injected into your body.”
Listen at 23:50
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s genetic switchesPositiveOct 5, 2026· Business Of Biotech
Early’s genetic switches are designed to activate only in cancer cells.
“they're designed to only turn on in cancer cells.”
Listen at 24:05
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s genetic switchesPositiveOct 5, 2026· Business Of Biotech
Early’s switches program cancer cells to produce local immune-activating drugs.
“when they turn on, they program the cancer cell to become their own drug factory to make a drug against themselves by activating the immune system locally to attack and kill the cancer.”
Listen at 24:10
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s lung-cancer therapyPositiveOct 5, 2026· Business Of Biotech
Early plans first-human dosing in late-stage lung cancer by summer 2027.
“if all goes well, we want to dose the first human patients in late stage lung cancer by the summer of next year.”
Listen at 25:49
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on conventional lipid nanoparticlesNegativeOct 5, 2026· Business Of Biotech
Conventional lipid nanoparticles primarily deliver cargo to the liver.
“The FedEx truck knows only one destination. It takes you to the liver.”
Listen at 27:09
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s FlexCore lipid nanoparticlesPositiveOct 5, 2026· Business Of Biotech
Early’s FlexCore nanoparticles deliver genetic cargo to tissues and tumors beyond the liver.
“we developed this new technology called FlexCore, which is a very different formulation and composition of the LNPs. And it allows us not only to get to other tissues, but to get into tumors”
Listen at 30:01
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s lipid nanoparticlesPositiveOct 5, 2026· Business Of Biotech
Early’s LNPs transfect tumor cells about 22 times more effectively than market standard.
“Our LNPs are like, I think, 22 times higher transfecting these cells, these tumor cells, than what's currently market standard.”
Listen at 30:26
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s AI-DNA design flywheelPositiveOct 5, 2026· Business Of Biotech
Early’s AI-DNA design flywheel improves with each iteration.
“with every turn of this flywheel, it gets stronger and smarter and stronger and smarter.”
Listen at 37:40
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s DNA platformPositiveOct 5, 2026· Business Of Biotech
Early’s platform makes DNA programmable.
“We make DNA programmable.”
Listen at 38:00
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s therapyPositiveOct 5, 2026· Business Of Biotech
Early’s therapy has shown exceptional safety in non-human primates.
“It's exceptionally safe.”
Listen at 39:39
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on Early’s therapyPositiveOct 5, 2026· Business Of Biotech
Early’s therapy did not mildly elevate monkey temperatures in testing.
“our monkeys are not even showing elevated mildly, not even mildly elevated temperature levels because we have engineered this out.”
Listen at 39:48
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on China’s 2026–2030 biotech planPositiveOct 5, 2026· Business Of Biotech
China will fulfill its 2026–2030 biotech plan.
“first off, I think this plan will be absolutely fulfilled.”
Listen at 41:50
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on ChinaPositiveOct 5, 2026· Business Of Biotech
China is an innovation powerhouse in biotech.
“China is an innovation powerhouse.”
Listen at 42:44
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on drug developmentNegativeOct 5, 2026· Business Of Biotech
Drug development takes 12 to 15 years from start to finish.
“It takes 12 to 15 years to develop a drug from start to finish.”
Listen at 46:10
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on AI venture fundingNeutralOct 5, 2026· Business Of Biotech
AI receives 87.5% of venture capital dollars this year.
“87.5%.”
Listen at 47:24
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on China’s pharmaceutical licensing sharePositiveOct 5, 2026· Business Of Biotech
China’s share of pharmaceutical licensing dollars will reach two-thirds this year.
“five years ago, less than 5% of the licensing dollars from pharma companies went to China. This year, it will be two-thirds.”
Listen at 47:49
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on U.S. sovereign biotech wealth fundPositiveOct 5, 2026· Business Of Biotech
The United States should establish a sovereign biotech wealth fund.
“the answer to this question, I believe, needs to be a sovereign biotech wealth fund.”
Listen at 49:24
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on sovereign biotech wealth fundPositiveOct 5, 2026· Business Of Biotech
A sovereign biotech wealth fund can mitigate biotech funding cycles.
“a sovereign wealth fund can fix this.”
Listen at 50:56
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on sovereign biotech wealth fundPositiveOct 5, 2026· Business Of Biotech
The fund should initially co-invest only with the top-performing 10% of VCs.
“My suggestion would be that in the beginning, for the first few years, until you see it's going well. The sovereign wealth fund is only allowed to co-invest with the top 10% best performing VCs of the world.”
Listen at 54:56
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on AI-driven human extinctionNegativeOct 5, 2026· Business Of Biotech
AI could eliminate the human species within 10 or 15 years.
“it's definitely a possibility”
Listen at 56:25
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on AI in medicinePositiveOct 5, 2026· Business Of Biotech
AI may help treat or cure some of humanity’s worst diseases.
“Where we see AI literally help not only treat, but potentially cure some of the worst diseases humanity has experienced.”
Listen at 56:57
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
on defensive AIPositiveOct 5, 2026· Business Of Biotech
Society should develop defensive AI to counter AI threats.
“We have to develop, out-innovate the threats of AI by innovating against them.”
Listen at 58:38
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.